REVB did a 1-for-7 reverse split on Oct 20, 2026. Fund positions use its last close before the split, $0.4850 on Oct 16, 2026, until the new shares are matched.

Revelation Biosciences, Inc.
REVB institutional ownership changes in Q2 2026: 4 institutions opened or added positions, 3 trimmed or exited. REVB (Revelation Biosciences, Inc.) is held by 8 institutional investors as of Q2 2026. Top institutional shareholders: Citadel Advisors LLC ($39,736), Geode Capital Management, LLC ($17,707), HRT Financial LP ($17,000). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Aug 18, 2026 · Activists Aug 14, 2026 · Congress none
Top Holders
| Insider | Trade | Traded |
|---|---|---|
| Rolke James | Vest 208K sh | |
| Chawla Lakhmir S | Vest 32K sh | |
| Zygmont Chester Stanley III | Gift 208K sh | |
| Zygmont Chester Stanley III | Gift 208K sh | |
| Zygmont Chester Stanley III | Vest 208K sh | |
| CARVER JENNIFER | Vest 32K sh | |
| ROPER JESS | Vest 32K sh | |
| Zygmont Chester Stanley III | Tax 13K sh | |
| Rolke James | Tax 10K sh | |
| Rolke James | Vest 533K sh |
| Filer | Stake | Filed |
|---|---|---|
| Armistice Capital, LLC | 5.0% | |
| Armistice Capital, LLC | 7.8% |
Continue exploring
Questions investors ask about REVB
Who owns REVB?
8 institutional investors held REVB on June 30, 2026, led by Citadel Advisors LLC ($39,736), Geode Capital Management, LLC ($17,707) and HRT Financial LP ($17,000).
How many hedge funds hold REVB?
8 institutional investors reported REVB in their 13F filings for the quarter ended June 30, 2026, $89,146 in all.
Are institutions buying or selling REVB?
Buying, on balance. In Q2 2026, 4 institutions opened or added to positions in REVB and 3 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer